Rocket Pharmaceuticals In... (RCKT)
Rocket Pharmaceuticals Max Pain By Strike
RCKT trades at $3.04, 21.6% above the near-term max pain of $2.5 expiring Aug 15, 2025 (-1 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($2.5-$2.5), indicating stable market expectations. Key magnetic zone at 3 where 7 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Rocket Pharmaceuticals Max Pain By Expiry
Max pain for RCKT shows stable levels around 2.50, reflecting balanced market expectations. The 0% spread suggests strong consensus on fair value. Most levels below 3.04 may cap rallies. Strong magnetic level at 3 (7 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 2.5 | -0.54 (-17.90%) |
| Sep 19, 2025 | 2.5 | -0.54 (-17.90%) |
| Oct 17, 2025 | 2.5 | -0.54 (-17.90%) |
| Nov 21, 2025 | 2.5 | -0.54 (-17.90%) |
| Dec 19, 2025 | 2.5 | -0.54 (-17.90%) |
| Jan 16, 2026 | 2.5 | -0.54 (-17.90%) |
| Apr 17, 2026 | 2.5 | -0.54 (-17.90%) |